Anders Engeland

Stilling: professor II

Telefon: 53 20 40 42

E-post: Anders.Engeland@isf.uib.no

Besøksadresse: Kalfarveien 31

Legemiddelepidemiologi

Kreftepidemiologi

Cand. Scient. (matematisk statistikk)

Dr. philos. i kreftepidemiologi

Publikasjoner i Cristin

Publikasjoner i tidsskrift med referee-ordning

1. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Magnus K, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer incidence in the Nordic countries up to the years 2000 and 2010. A collaborative study of the five Nordic cancer registries. APMIS Suppl 1993; 38: 1–124.

2. Paus E, Theodorsen L, Engeland A. Prostate-specific antigen in serum from blood donors with subsequent cancer prostate diagnosis. Eur J Can­cer 1993, 29A, 1221–2.

3. Magnus K, Engeland A, Green BMR, Haldorsen T, Muirhead CR, Strand T. Residential radon exposure and lung cancer. An epidemiological study of Norwegian municipalities. Int J Cancer 1994; 58: 1–7.

4. Grøndahl AM, Gaustad G, Engeland A. Progression and association with lameness and racing performance of radiographic changes in the proximal sesamoid bones of young standardbred trotters Equine Vet J 1994; 26: 152–5. 

5. Engeland A, Haldorsen T, Tretli S. [Prediction of cancer mortality based on relative survival analysis] Prediksjon av kreftdødelighet basert på relativ overlevelsesanalyse. Nor Epidemiol 1994; 4: 82–5.

6. Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prediction of cancer mortality in the Nordic countries up to the Years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries. APMIS Supplement 1995; 49: 1–163.

7. Grøndahl AM, Engeland A. Influence of radiographically orthopedic changes on racing performance in Standardbred trotters. J Am Vet Med Ass 1995; 206: 1013-7.

8. Tretli S, Engeland A, Haldorsen T, Hakulinen T, Hörte LG, Luostarinen T, Schou G, Sigvaldason H, Storm HH, Tulinius H, Vaittinen P. Prostate cancer–Look to Denmark? Letter. J Natl Cancer Inst 1996; 88: 128.

9. Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years’ observation of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 366–76.

10. Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years’ follow-up of 26,000 Norwegian men and women. Cancer Causes Control 1996; 7: 497–506.

11. Andersen A, Berge SR, Engeland A, Norseth T. Exposure to nickel com­pounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery work­ers. Occup Env Med. 1996; 53: 708–13.

12. Engeland A. Trends in the incidence of smoking-associated cancers in Norway, 1954–93. Int J Cancer 1996; 68: 39–46.

13. Engeland A, Bjørge T, Haldorsen T, Tretli S. Use of multiple primary cancers to indicate associations between smoking and cancer incidence. An analysis of 500,000 cancer cases diagnosed in Norway during 1953–93. Int J Cancer 1997; 70: 401-7.

14. Hafstad A, Aarø LE, Engeland A, Andersen A, Langmark F, Stray-Pedersen B. Provocative appeals in anti-smoking mass media campaigns targeting adolescent - the accumulated effect of multiple exposures. Health Education Research 1997; 12: 227-36.

15. Bjørge T, Engeland A, Hansen S, Tropé C. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954–93. Int J Cancer 1997; 71: 780-6.

16. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. A prospective, seroepidemiological study of the role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 346-9.

17. Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J. Prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res 1997; 57: 3989-92.

18. Daae LNW, Engeland A, Freng A. [Experiences from serum protein investigations in patients with recently discovered malignant tumors in the upper digestive tract] Serumproteiner hos pasienter med nyoppdaget kreft i munn­hule/svelg. Hvilken lærdom gav konsentrasjonsmåling og elektroforese? Tidsskr Nor Laegeforen 1997; 117: 3671-3.

19. Engeland A, Bjørge T, Haldorsen T, Tretli S. Prognosis of patients with lung cancer diagnosed in Norway, 1954-1993. Cancer Causes Control 1998; 9: 57-65.

20. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, Tulinius H. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncol 1998; 37: 49-59.

21. Bjørge T, Engeland A, Hansen S, Tropé CG. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 1998; 75: 663-70.

22. Freng A, Daae LNW, Engeland A, Norum KR, Sander J, Solvoll K, Tretli S. Malignant epithelial tumours in the upper digestive tract: a dietary and socio-medical case-control and survival study. Eur J Clin Nutr 1998; 52: 271-8.

23. Engeland A, Bjørge T. [Passive smoking and risk of cancer] Passiv røyking og kreftrisiko. Tidsskr Nor Laegeforen 1998; 118: 2183-6.

24. Bjørge T, Engeland A, Hansen S, Tropé CG. [Ovarian cancer and borderline tumours.] Ovarialcancer og borderlinetumorer. Tidsskr Nor Laegeforen 1998; 118: 2471-5.

25. Grimsrud TK, Langseth H, Engeland A, Andersen A. Lung and bladder cancer in a Norwegian municipality with iron and steel producing industry: population based case-control studies. Occup Env Med 1998; 55: 387-92.

26. Bjørge T, Engeland A, Sundfør K, Tropé CG. Prognosis of 2,800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstet Gynecol Scand 1998; 77: 777-81.

27. Storm HH, Dickman PW, Engeland A, Haldorsen T, Hakulinen T. Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J. 1999; 13: 430-5.

28. Engeland A, Kopjar B. [Injuries among children] Skader blant barn behandlet ved legevakt og i sykehus 1990-97. Tidsskr Nor Laegeforen 1999; 119: 784-7.

29. Berg JP, Engeland A, Jellum E, Glattre E. Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case-control study. Thyroid 1999; 9: 285-8.

30. Bjørge T, Tropé CG, Engeland A. [Screening for cancer] Screening mot kreft. Tidsskr Nor Laegeforen 1999; 119: 1129-36.

31. Andersen A, Barlow L, Engeland A, Kjærheim K, Lynge E, Pukkala E. Work-related cancer in the Nordic countries. Scand J Work Environ Health 1999; 25 suppl 2: 1-116.

32. Engeland A, Kopjar B. [Injuries from violence in Norway - analysis of the data from the Norwegian National Injury Sample Registry] Voldsskader i Norge - en analyse av data fra personskaderegisteret. Tidsskr Nor Laegeforen 2000; 120: 714-7.

33. Kopjar B, Engeland A, Bjørndal A. Impact of the Safe Community program in Harstad on the incidence of injuries. Injury Control Saf Promotion 2000; 7: 29-39.

34. Myklestad I, Engeland A. . [Product-related home injuries among pre-school children] Hjemmeulykker blant småbarn og potensiale for forebygging. Tidsskr Nor Laegeforen 2000; 120: 3376-9.

35. Sjølingstad A, Alvær K, Engeland A, Forsén L. [Registration of external causes of injuruy by ICD-10 in Norwegian hospitals] Skaderegistrering ved hjelp av ICD-10 ved norske sykehus. Tidsskr Nor Laegeforen 2001; 121: 1052-4.

36. Engeland A, Wiik J, Lande G. [Registration of parasuicide at hospitals and emergency wards] Registrering av parasuicid ved sykehus og legevakt. Tidsskr Nor Laegeforen 2001; 121: 1033-7.

37. Glattre E, Engeland A, Jellum E, Høstmark AT. Serum-albumin and risk of thyroid cancer: A population-based, matched case-control study. Nor Epidemiol 2001; 11: 197-200.

38. Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 2002; 87: 61-4. Erratum in Br J Cancer 2004; 91: 1226.

39. Bjørge T, Engeland A. [P-pills and risk of cancer] Bruk av p-piller og risiko for kreft. Tidsskr Nor Laegeforen 2002; 122: 1788-90.

40. Engeland A, Røysamb E, Smedslund G, Søgaard AJ. Effects of first-aid training in junior high schools. Injury Control Saf Promotion 2002; 9: 99-106.

41. Engeland A, Bjørge T, Søgaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality: 32-year follow-up of 227,000 Norwegian boys and girls. Am J Epidemiol 2003; 157: 517-23.

42. Engeland A, Bjørge T, Selmer RM, Tverdal A. Height and body mass index in relation to total mortality. Epidemiology 2003; 14: 293-9.

43. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer: A follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 2003: 95: 1244-8.

44. Engeland A, Søgaard AJ. [CONOR (COhort NORway) - an overview of a unique research material] CONOR (COhort NORway) - en oversikt over en unik forskningsdatabank. Nor Epidemiol 2003; 13: 73-7.

45. Engeland A, Tretli S, Bjørge T. Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men. Br J Cancer 2003; 89: 1237-42.

46. Engeland A, Bjørge T, Tverdal A, Søgaard AJ. Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology 2004; 15: 79-85.

47. Engeland A, Bjørge T, Tretli S. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004; 15: 837-43.

48. Nystad W, Meyer HE, Nafstad P, Tverdal A, Engeland A. Body mass index in relation to adult asthma among 135,000 Norwegian men and women. Am J Epidemiol 2004; 160: 969-76.

49. Bjørge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 2004; 160: 1168-76.

50. Engeland A, Tretli S, Austad G, Bjørge T. Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes Control 2005; 16: 987-96.

51. Bjørge T, Tretli S, Engeland A. Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. Br J Cancer 2005; 93: 807-10.

52. Flugsrud GB, Nordsletten L, Espehaug B, Havelin LI, Engeland A, Meyer HE. The impact of BMI on later total hip arthroplasty due to primary osteoarthritis. A cohort study in 1.2 million persons. Arthritis Rheum 2006; 54: 802-7.

53. Bramness JG, Skurtveit S, Furu K, Engeland A, Sakshaug S, Rønning M. Endringer i salg og bruk av flunitrazepam i perioden 1999-2004. [Changes in the sale and use of flunitrazepam in Norway, 1999 - 2004.] Tidsskr Nor Laegeforen 2006; 126: 589-90.

54. Strøm H, Engeland A, Eriksen E, Rønning M. [How many and who are receiving medication for treatment of diabetes mellitus in Norway?] Hvor mange og hvem (alder og kjønn) behandles medikamentelt for diabetes mellitus i Norge? Tidsskr Nor Laegeforen  2006; 126: 768–70.

55. Bjørge T, Tretli S, Lie AK, Engeland A. The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes Control 2006; 17: 983-7.

56. Engeland A , Tretli S, Akslen LA, Bjørge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006; 95: 366-70.

57. Bjørge T, Engeland A, Tretli S, Weiderpass E. Body mass size in relation to cancer of the uterine corpus in one million Norwegian women. Int J Cancer 2007; 120, 378–83.

58. Engeland A, Tretli S, Hansen S, Bjørge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol 2007; 165: 44-52.

59. Bramness JG, Furu K, Engeland A, Skurtveit S. Carisoprodol use and abuse – a pharmacoepidemiological study. Br J Clin Pharmaco 2007; 64: 210-8.

60. Blix HS, Engeland A, Litleskare I, Rønning M. Age and gender -specific antibacterial prescribing in Norway. J Antimicr Chem 2007; 59:971-6.

61. Bramness JG, Skurtveit S, Mørland J, Engeland A. The risk of traffic accidents after prescriptions of carisoprodol. Accid Anal Prev 2007; 39:1050-55.

62. Engeland A, Skurtveit S, Mørland J. Risk of road traffic accidents associated with the prescription of drugs: a registry-based cohort study. Ann Epidemiol. 2007, 17: 597-602.

63. Anderssen SA, Engeland A, Søgaard AJ, Nystad W, Graff-Iversen S, Holme I. Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scand J Med Sci Sports 2008; 18: 309-17.

64. Bramness JG, Engeland A, Furu K. Antidepressiver hos barn og ungdom – førte advarsler til færre forskrivninger? [Use of antidepressants among children and adolescents - did the warnings lead to fewer prescriptions?] Tidsskr Nor Laegeforen  2007; 127: 2653–5.

65. Næss Ø, Søgaard AJ, Arnesen E, Beckstrøm AC, Bjertness E, Engeland A, Hjort PF, Holmen J, Magnus P, Njølstad I, Tell GS, Vatten L, Vollset SE, Aamodt G. Cohort Profile: Cohort of Norway (CONOR). Int J Epidemiol 2008; 37: 481-5.

66. Hartz I, Sakshaug S, Furu K, Engeland A, Eggen AE, Njølstad I, Skurtveit S. Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clin Pharmacol 2007; 7: 14.

67. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel CI, Mørland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008; 9: 818-22.

68. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-06. Br J Clin Pharmaco 2008; 69: 653-60.

69. Bjørge T, Cnattingius S, Lie RT, Tretli S, Engeland A. Cancer risk in children with birth defects and in their families. A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiol Biomarkers Prev 2008: 17: 500-6.

70. Bjørge T, Engeland A, Tverdal A, Davey Smith G. Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. Am J Epidemiol 2008; 168: 30-7.

71. Engeland A, Bramness JG, Mørland J, Skurtveit S. Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. [Traffic accident risks associated with the prescription of medicinal drugs: a registry-based cohort study.] Nor Epidemiol 2008; 18: 159-65. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

72. Bachs LC, Bramness JG, Engeland A, Skurtveit S. Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Nor Epidemiol 2008; 18; 185-90. http://www.ub.ntnu.no/journals/norepid/2008-2.html.

73. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway.  J Clin Psychiat 2008; 69: 1099-103.

74. Bjørge T, Engeland A, Tretli S, Heuch I. Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study.  Br J Cancer 2008; 99: 1165-9.

75. Hausken AM, Furu K, Skurtveit S, Engeland A, Bramness JG. Starting insomnia treatment: The use of benzodiazepines versus z-hypnotics.A prescription database study of predictors. Eur J Clin Pharmacol 2009; 65: 295-301.

76. Bramness JG, Grøholt B, Engeland A, Furu K. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study. J Affect Disord. 2009; 117: 208-11.

77. Bachs L, Engeland A, Mørland J, Skurtveit S. The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol. Clin Pharmacol Ther 2009; 85: 596-9.

78. Skurtveit S, Strøm H, Skrivarhaug T, Mørland J, Bramness JG, Engeland A. Road traffic accident risk in patients with diabetes mellitus, receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Med 2009; 26: 404-8.

79. Bramness JG, Skurtveit S, Neutel CI, Mørland J, Engeland A. An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiol Drug Saf 2009; 18: 492-6.

80. Bjørge T, Cnattingius S, Engeland A, Tretli S, Lie RT, Lukanova A. Fetal Down syndrome and the risk of maternal breast cancer. Epidemiology 2009; 20: 584-89.

81. Viktil KK, Engeland A, Furu K. Use of antirheumatic drugs in mothers and fathers before and during pregnancy – a population based cohort study. Pharmacoepidemiol Drug Saf 2009: 18: 737-42.

82. Engeland A, Bjørge T, Daltveit AK, Vollset SE, Furu K. Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstet Gynecol Scand 2009; 88: 1083-9.

83. Stocks T, Borena W, Strohmaier S, Bjørge T, Manjer J, Engeland A, Johansen D, Selmer R, Hallmans G, Rapp K, Concin H, Jonsson H, Ulmer H, Stattin P. Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol 2010; 39: 660-7.

84. Bjørge T, Stocks T, Lukanova A, Tretli S, Selmer R, Manjer J, Rapp K, Ulmer H, Almquist M, Concin H, Hallmans G, Jonsson H, Stattin P, Engeland A. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892-902.

85. Bramness JG, Sandvik P, Engeland A, Skurtveit S. Does pregabalin (Lyrica^®) help patients reduce their use of benzodiazepines? A comparison with gabapentin using the Norwegian Prescription Database. Basic Clin Pharmacol 2010

86. Andersen JB, Engeland A, Owe JF, Gilhus NE. Myasthenia gravis requiring drug treatment in a national population cohort. Eur J Neurol 2010; 17: 1445-50.

87. Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P. Metabolic syndrome and risk of Bladder cancer. Prospective cohort study in Metabolic syndrome and Cancer project (Me-Can). Int J Cancer 2010.

88. Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and cancer) project. Cancer Epidemiol Biomarkers Prev 2010; 19:1737-45.

89. Johansen D, Stocks T, Jonsson H, Lindkvist B, Bjørge T, Concin H, Almquist M, Häggström C, Engeland A, Ulmer H, Hallmans G, Selmer R, Nagel G, Tretli S, Stattin P, Manjer J.  Metabolic Factors and the Risk of Pancreatic cancer: A Prospective analysis of almost 600,000 men and women in the Me-Can project. Cancer Epidemiol Biomarkers Prev 2010; 19: 2307-17.

90. Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G , Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer, Stattin P, Lukanova A. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Ann Oncol 2010.

91. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel  G, Bjørge T,  Manjer J, Hallmans G, Selmer R, Almquist M, Häggstöm C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P,Ulmer H^. Serum triglycerides and cancer risk in the Me-Can Collaborative Study. Cancer Causes Control 2011; 22: 291-9.

92. Stocks T, Lukanova A,Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and risk of colorectal cancer in 580,000 men and women in the Metabolic syndrome and Cancer project (Me-Can): a pooled cohort study. Cancer 2010.

93. Espnes MG, Bjørge T, Engeland A. Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiol Drug Saf  2011; 20: 243-8.

94. Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K. Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. Eur J Epidemiol 2011; 26: 157-63.

95. Almquist M, Johansen D, Bjørge T, Ulmer H, Lindkvist B, Stocks T, Hallmans G, Engeland A, Rapp K, Jonsson H, Selmer R, Diem G, Häggström C, Tretli S, Stattin P, Manjer J. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can): a prospective analysis of 580,000 men and women. Cancer Causes Control 2011.

96. Handal M, Engeland A, Rønning M, Skurtveit S, Furu K. Use of prescribed opioid analgesic in women before, during and after pregnancy. A population based cohort study. Eur J Clin Pharm 2011.

• Underviser på kurs i epidemiologi for medisiner- og PhD studenter
• Veileder medisinerstudenter (særoppgave) og PhD studenter

• Medikamentbruk i forbindelse med svangerskap

• Veitrafikkulykker knyttet til forskrivning av legemidler

• Legemiddelbruk og hoftebrudd

• Metabolsk syndrom og kreft

• Forhold under graviditet og fødselskarakteristika i relasjon til kreft blant barn og ungdom
• Kreftrisiko i familier med barn med medfødte misdannelser

 

Livsstilsepidemiologi